These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32218781)

  • 1. Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis.
    Queck A; Bode H; Uschner FE; Brol MJ; Graf C; Schulz M; Jansen C; Praktiknjo M; Schierwagen R; Klein S; Trautwein C; Wasmuth HE; Berres ML; Trebicka J; Lehmann J
    Front Immunol; 2020; 11():354. PubMed ID: 32218781
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality.
    Lehmann JM; Claus K; Jansen C; Pohlmann A; Schierwagen R; Meyer C; Thomas D; Manekeller S; Claria J; Strassburg CP; Trautwein C; Wasmuth HE; Berres ML; Trebicka J
    Liver Int; 2018 May; 38(5):875-884. PubMed ID: 29105936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.
    Fisher NC; Neil DA; Williams A; Adams DH
    Gut; 1999 Sep; 45(3):416-20. PubMed ID: 10446112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.
    Blaya D; Pose E; Coll M; Lozano JJ; Graupera I; Schierwagen R; Jansen C; Castro P; Fernandez S; Sidorova J; Vasa-Nicotera M; Solà E; Caballería J; Trebicka J; Ginès P; Sancho-Bru P
    JHEP Rep; 2021 Apr; 3(2):100233. PubMed ID: 33665588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
    Baeck C; Wei X; Bartneck M; Fech V; Heymann F; Gassler N; Hittatiya K; Eulberg D; Luedde T; Trautwein C; Tacke F
    Hepatology; 2014 Mar; 59(3):1060-72. PubMed ID: 24481979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
    Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
    Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
    Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis.
    Wirtz TH; Reuken PA; Jansen C; Fischer P; Bergmann I; Backhaus C; Emontzpohl C; Reißing J; Brandt EF; Koenen MT; Schneider KM; Schierwagen R; Brol MJ; Chang J; Zimmermann HW; Köse-Vogel N; Eggermann T; Kurth I; Stoppe C; Bucala R; Bernhagen J; Praktiknjo M; Stallmach A; Trautwein C; Trebicka J; Bruns T; Berres ML
    JHEP Rep; 2021 Apr; 3(2):100221. PubMed ID: 33659891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
    Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure.
    Mehta G; Mookerjee RP; Sharma V; Jalan R
    Liver Int; 2015 Mar; 35(3):724-34. PubMed ID: 24703488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse.
    Ajuebor MN; Hogaboam CM; Le T; Swain MG
    J Immunol; 2003 May; 170(10):5252-9. PubMed ID: 12734374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study.
    Roth GA; Faybik P; Hetz H; Ankersmit HJ; Hoetzenecker K; Bacher A; Thalhammer T; Krenn CG
    Scand J Gastroenterol; 2009; 44(6):745-51. PubMed ID: 19247846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.
    Laursen TL; Rødgaard-Hansen S; Møller HJ; Mortensen C; Karlsen S; Nielsen DT; Frevert S; Clemmesen JO; Møller S; Jensen JS; Bendtsen F; Grønbaek H
    Liver Int; 2017 Apr; 37(4):569-575. PubMed ID: 27706896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
    Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
    Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
    Tsuneyama K; Harada K; Yasoshima M; Hiramatsu K; Mackay CR; Mackay IR; Gershwin ME; Nakanuma Y
    J Pathol; 2001 Jan; 193(1):102-9. PubMed ID: 11169522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.
    Marra F; DeFranco R; Grappone C; Milani S; Pastacaldi S; Pinzani M; Romanelli RG; Laffi G; Gentilini P
    Am J Pathol; 1998 Feb; 152(2):423-30. PubMed ID: 9466568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver.
    Hokeness KL; Kuziel WA; Biron CA; Salazar-Mather TP
    J Immunol; 2005 Feb; 174(3):1549-56. PubMed ID: 15661915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.